Literature DB >> 1524519

Vascular event rates in patients with atherosclerotic cerebrovascular disease.

J L Wilterdink1, J D Easton.   

Abstract

The purpose of this study was to review data from published cerebrovascular studies to determine if it is possible to predict, based on clinical manifestations (eg, cervical bruit, transient ischemic attack, or stroke) of cerebrovascular atherosclerosis, the annual probability of having a stroke, as well as to determine and discuss the methods used in calculating and reporting vascular event rates. This overview analysis reveals that the annual stroke rates are as follows: for asymptomatic carotid stenosis, 1.3% (95% confidence interval [CI], 1.0 to 1.6); for transient monocular blindness, 2.2% (95% CI, 1.3 to 3.0); for transient ischemic attack, 3.7% (95% CI, 3.1 to 4.3); for minor stroke, 6.1% (95% CI, 5.7 to 6.6); and for major stroke, 9.0% (95% CI, 8.0 to 9.9). The data analyzed here suggest that a hierarchical profile of worsening clinical characteristics mirrors a hierarchical progression of increasing risk of stroke. These data support the idea that there is a clinical risk profile, in addition to the conventional atherosclerosis risk factor profile, for predicting subsequent stroke.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1524519     DOI: 10.1001/archneur.1992.00530320089016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  25 in total

1.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

2.  A 65-year-old man with transient monocular vision loss.

Authors:  Sean Kennedy; Jason Noble; Agnes Wong
Journal:  CMAJ       Date:  2014-05-20       Impact factor: 8.262

3.  Risk factors and incidence for peripheral arterial disease in patients with typical lumbar spinal stenosis.

Authors:  Min-Hee Han; Dong-Hyun Lee; Ki-Su Park; Young-Seok Lee; Kyoung-Tae Kim; Joo-Kyung Sung; Hyung-Kee Kim; Dae-Chul Cho
Journal:  Korean J Spine       Date:  2014-09-30

4.  Type of stroke after transient monocular blindness or retinal infarction of presumed arterial origin.

Authors:  E L L M De Schryver; A Algra; R C J M Donders; J van Gijn; L J Kappelle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02-24       Impact factor: 10.154

Review 5.  Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.

Authors:  Jesse Weinberger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Antithrombotic Secondary Prevention After Stroke.

Authors:  Hans-Christoph Diener; Peter Ringleb
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.598

7.  Echomorphologic and histopathologic characteristics of unstable carotid plaques.

Authors:  T J Tegos; M Sohail; M M Sabetai; P Robless; N Akbar; G Pare; G Stansby; A N Nicolaides
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

Review 8.  Stroke Best Practices: a team approach to evidence-based care.

Authors:  Mark J Alberts; J Donald Easton
Journal:  J Natl Med Assoc       Date:  2004-04       Impact factor: 1.798

9.  Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study.

Authors:  T Rundek; H Arif; B Boden-Albala; M S Elkind; M C Paik; R L Sacco
Journal:  Neurology       Date:  2008-03-19       Impact factor: 9.910

10.  Ticlopidine hydrochloride use and threatened stroke.

Authors:  J F Rothrock; R G Hart
Journal:  West J Med       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.